For the first time, WHO’s treatment pointers consist of a transparent recommendation for the usage of lengthy-acting injectable cabotegravir and rilpivirine (Taxi/RPV) in its place switching option for antiretroviral therapy (ART) for Older people and adolescents who've realized whole viral suppression on oral ART and don't have Energetic hepatitis B https://goo.gl/maps/UueY6cwcpDNXRohh7